Showing results (61-70 of 406) with videos related to
Sort By:
Pageof 41
The American Journal of Surgical Pathology|February 1, 1992
CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of diseaseJ T Sundeen, D L Longo, E S JaffeJournal of the National Cancer Institute. Monographs|January 1, 1990
Treatment of patients with aggressive lymphomas: an overviewW J Urba, P L Duffey, D L LongoProceedings of the National Academy of Sciences of the United States of America|May 15, 1992
Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient miceW J Murphy, S K Durum, D L LongoThe Journal of Experimental Medicine|May 1, 1989
Preferential differentiation of T cell receptor specificities based on the MHC glycoproteins encountered during development. Evidence for positive selectionS Marusić-Galesić, D L Longo, A M KruisbeekScience (New York, N.Y.)|July 3, 1987
T-cell tumor elimination as a result of T-cell receptor-mediated activationJ D Ashwell, D L Longo, S H BridgesThe New England Journal of Medicine|June 27, 1985
Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotypeM Raffeld, L Neckers, D L Longo, et al.Cancer|October 15, 1987
Biologic therapy for the treatment of malignant common epithelial tumors of the ovaryT C Hamilton, R F Ozols, D L LongoCancer|February 1, 1987
Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphomaR G Steis, K A Foon, D L LongoJournal of the National Cancer Institute. Monographs|January 1, 1990
Late complications of Hodgkin's disease managementR C Young, M A Bookman, D L LongoBiochemical and Biophysical Research Communications|October 4, 1995
Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation productC C Li, R M Dai, D L LongoPageof 41